Asthmaware is a health-tech startup that operates in the medical technology market, specifically focusing on pediatric respiratory health. The company's primary product is a wearable technology system designed to monitor and manage asthma symptoms in children. This system comprises a smart-textile shirt and a mobile application, which work together to evaluate a child's breathing activity during sleep using sEMG technology (surface electromyography, a non-invasive method of measuring muscle activity).

The company's target clients are children suffering from asthma and other respiratory diseases, as well as their caregivers and healthcare providers. Asthmaware's system is designed to help children recognize early symptoms of an asthma attack, particularly nocturnal symptoms, which are often overlooked but can be a significant indicator of an impending attack. The system also aids in understanding the relationship between triggers and symptoms and quantifies responsiveness to therapy. This data-driven approach not only facilitates decision-making for doctors but also improves medication perception for children, leading to better self-management of the disease.

Asthmaware's business model revolves around the sale of its wearable technology and the accompanying mobile application. The company generates revenue from the direct sale of these products to consumers, as well as potentially from partnerships with healthcare providers or insurance companies who may offer the system as part of a comprehensive care package for pediatric asthma patients.

Keywords: Asthma, Pediatric Health, Wearable Technology, Respiratory Monitoring, sEMG Technology, Mobile Application, Self-Management, Symptom Recognition, Data-Driven Healthcare, Chronic Disease Management.